<?xml version="1.0" encoding="UTF-8"?>
<p>Various CNS active Indian herbal medicines like 
 <italic>Withania somnifera</italic>, 
 <italic>Centella asiatica</italic>, 
 <italic>Celastrus paniculatus</italic> and 
 <italic>Bacopa monnieri</italic> have shown cognitive improvement in experimental models of AD when given as prophylactic treatment [
 <xref rid="B43-brainsci-10-00964" ref-type="bibr">43</xref>,
 <xref rid="B44-brainsci-10-00964" ref-type="bibr">44</xref>,
 <xref rid="B45-brainsci-10-00964" ref-type="bibr">45</xref>,
 <xref rid="B46-brainsci-10-00964" ref-type="bibr">46</xref>,
 <xref rid="B47-brainsci-10-00964" ref-type="bibr">47</xref>,
 <xref rid="B48-brainsci-10-00964" ref-type="bibr">48</xref>]. A randomized, double-blind exploratory trial reported comparable efficacy of a 
 <italic>Gingko biloba</italic> extract and donepezil in AD patients with associated neuropsychiatric problems. The combination was reported to be superior to donepezil monotherapy in terms of both safety and efficacy [
 <xref rid="B49-brainsci-10-00964" ref-type="bibr">49</xref>].
</p>
